A novel de-novo frameshift mutation of the ASXL1 gene in a classic case of Bohring-Opitz syndrome

被引:8
作者
Arunachal, Gautham [1 ]
Danda, Sumita [1 ]
Omprakash, Sabita [1 ]
Kumar, Sathish [2 ]
机构
[1] MGR Univ, Dept Clin Genet, Christian Med Coll, Vellore, Tamil Nadu, India
[2] MGR Univ, Dept Paediat, Christian Med Coll, Vellore, Tamil Nadu, India
关键词
D O I
10.1097/MCD.0000000000000126
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:101 / 105
页数:5
相关论文
共 7 条
[1]   ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression [J].
Abdel-Wahab, Omar ;
Adli, Mazhar ;
LaFave, Lindsay M. ;
Gao, Jie ;
Hricik, Todd ;
Shih, Alan H. ;
Pandey, Suveg ;
Patel, Jay P. ;
Chung, Young Rock ;
Koche, Richard ;
Perna, Fabiana ;
Zhao, Xinyang ;
Taylor, Jordan E. ;
Park, Christopher Y. ;
Carroll, Martin ;
Melnick, Ari ;
Nimer, Stephen D. ;
Jaffe, Jacob D. ;
Aifantis, Iannis ;
Bernstein, Bradley E. ;
Levine, Ross L. .
CANCER CELL, 2012, 22 (02) :180-193
[2]   De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome [J].
Bainbridge, Matthew N. ;
Hu, Hao ;
Muzny, Donna M. ;
Musante, Luciana ;
Lupski, James R. ;
Graham, Brett H. ;
Chen, Wei ;
Gripp, Karen W. ;
Jenny, Kim ;
Wienker, Thomas F. ;
Yang, Yaping ;
Sutton, V. Reid ;
Gibbs, Richard A. ;
Ropers, H. Hilger .
GENOME MEDICINE, 2013, 5
[3]   Bohring-Opitz Syndrome (BOS) with a New ASXL1 Pathogenic Variant: Review of the Most Prevalent Molecular and Phenotypic Features of the Syndrome [J].
Dangiolo, Silvana Beatriz ;
Wilson, Ashley ;
Jobanputra, Vaidehi ;
Anyane-Yeboa, Kwame .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (12) :3161-3166
[4]   Bohring-Opitz (Oberklaid-Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis [J].
Hastings, Rob ;
Cobben, Jan-Maarten ;
Gillessen-Kaesbach, Gabriele ;
Goodship, Judith ;
Hove, Hanne ;
Kjaergaard, Susanne ;
Kemp, Helena ;
Kingston, Helen ;
Lunt, Peter ;
Mansour, Sahar ;
McGowan, Ruth ;
Metcalfe, Kay ;
Murdoch-Davis, Catherine ;
Ray, Mary ;
Rio, Marlene ;
Smithson, Sarah ;
Tolmie, John ;
Turnpenny, Peter ;
van Bon, Bregje ;
Wieczorek, Dagmar ;
Newbury-Ecob, Ruth .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (05) :513-519
[5]   De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome [J].
Hoischen, Alexander ;
van Bon, Bregje W. M. ;
Rodriguez-Santiago, Benjamin ;
Gilissen, Christian ;
Vissers, Lisenka E. L. M. ;
de Vries, Petra ;
Janssen, Irene ;
van Lier, Bart ;
Hastings, Rob ;
Smithson, Sarah F. ;
Newbury-Ecob, Ruth ;
Kjaergaard, Susanne ;
Goodship, Judith ;
McGowan, Ruth ;
Bartholdi, Deborah ;
Rauch, Anita ;
Peippo, Maarit ;
Cobben, Jan M. ;
Wieczorek, Dagmar ;
Gillessen-Kaesbach, Gabriele ;
Veltman, Joris A. ;
Brunner, Han G. ;
de Vries, Bert B. B. A. .
NATURE GENETICS, 2011, 43 (08) :729-731
[6]   The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination [J].
Inoue, D. ;
Nishimura, K. ;
Kozuka-Hata, H. ;
Oyama, M. ;
Kitamura, T. .
LEUKEMIA, 2015, 29 (11) :2257-2260
[7]   Clinical Management of Patients with ASXL1 Mutations and Bohring-Opitz Syndrome, Emphasizing the Need for Wilms Tumor Surveillance [J].
Russell, Bianca ;
Johnston, Jennifer J. ;
Biesecker, Leslie G. ;
Kramer, Nancy ;
Pickart, Angela ;
Rhead, William ;
Tan, Wen-Hann ;
Brownstein, Catherine A. ;
Clarkson, L. Kate ;
Dobson, Amy ;
Rosenberg, Avi Z. ;
Vergano, Samantha A. Schrier ;
Helm, Benjamin M. ;
Harrison, Rachel E. ;
Graham, John M., Jr. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (09) :2122-2131